Search clinical trials for: Vasopressin V2 Receptor Antagonist

Total 9380 results

University of Malaya

Completed

Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome

Schizophrenia

Malaysia
Pfizer

Completed

Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia

Schizophrenia

United States, India, Russian Federation, Ukraine
Louisiana State University Health Sciences Center...
SAM Technology & The San Francisco Brain Research Institute

Terminated

Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI)

Schizophrenia | Schizoaffective Disorder

United States
Northwell Health
Bristol-Myers Squibb

Terminated

Aripiprazole Treatment of the Prodrome

Prodromal Schizophrenia | Prodromal Psychosis

United States
State University of New York - Upstate Medical...
Bristol-Myers Squibb

Completed

Aripiprazole as Augmentation for TRD

Depression

United States
Genovate Biotechnology Co., Ltd.,

Unknown

Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia

Dyslipidemia | Weight Gain | Hyperprolactinemia
AbbVie (prior sponsor, Abbott)

Completed

Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor (RADAR)

Diabetic Nephropathy | Chronic Kidney Disease

United States, Canada, Puerto Rico, Taiwan
Huazhong University of Science and Technology

Unknown

The Effect of Long-acting Antipsychotics on Schizophrenia Patients With Violence Risk

Schizophrenia

China
Pfizer

Terminated

A Study To Evaluate The Efficacy Of Eplerenone Compared With Losartan For The Treatment Of Patients With Mild To Moderate Hypertension

Hypertension

Taiwan
Medical University of Vienna

Completed

Endothelin-Receptor Blockade in Coronary Heart Disease

Vascular Resistance | Coronary Vessels | Endothelins

Austria
University of Southampton

Completed

Effect of Clopidogrel on Allergen Challenge in Asthma

Asthma

United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

Cangrelor Neonatal PK/PD and Safety Study

Partial Obstruction of Systemic to Pulmonary Artery Shunt | Complete Obstruction of Systemic to Pulmonary Artery Shunt

United States
Scripps Health
National Center for Research Resources (NCRR)

Completed

Pilot Study on the Effect of High Clopidogrel Maintenance Dosing (PREDICT)

Coronary Artery Disease

United States
Eli Lilly and Company

Completed

A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of Clopidogrel

Major Depressive Disorder

United States
National Institute of Diabetes and Digestive and...
Boston University; Washington University School of Medicine; University of Alabama... and other collaborators

Completed

Clopidogrel Prevention of Early Arteriovenous (AV) Fistula Thrombosis (FISTULA)

Kidney Failure | Hemodialysis Fistula Thrombosis

United States
Ottawa Heart Institute Research Corporation

Completed

Transition From Ticagrelor to Clopidogrel Following Acute Coronary Syndrome: To Bolus or Not?

Acute Coronary Syndrome

Canada
Boehringer Ingelheim

Completed

Influence of Clopidogrel on the Pharmacodynamics and Safety of Fradafiban in Healthy Male Subjects

Healthy
Boehringer Ingelheim

Completed

Influence of Clopidogrel on the Pharmacodynamics and Safety of Terbogrel in Healthy Male Subjects

Healthy
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Clopidogrel Tablets 75 mg of Dr. Reddy's Under Fasting Conditions

Fasting

Canada
University Hospital Tuebingen

Completed

Mirror Trial - Follow-Up Management of Peripheral Arterial Intervention With Clopidogrel

Peripheral Vascular Diseases

Germany
Sanofi
Bristol-Myers Squibb

Completed

PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on Inflammation in Subjects With Metabolic Syndrome

Metabolic Syndrome x

United States
Charles University, Czech Republic

Completed

Clopidogrel Only Before Percutaneous Coronary Intervention or Before Every Coronarography?

Ischemic Heart Disease

Czech Republic
Chiang Mai University

Unknown

Effect of Add-on Spironolactone to Losartan Versus Losartan Alone on Peritoneal Membrane Among Peritoneal Dialysis Patients (ESCAPE-PD)

Peritoneal Dialysis | End Stage Renal Disease

Thailand
Chinook Therapeutics U.S., Inc.

Active, not recruiting

Atrasentan in Patients With Proteinuric Glomerular Diseases (AFFINITY)

Diabetic Kidney Disease | Focal Segmental Glomerulosclerosis | Immunoglobulin A Nephropathy | IgA Nephropathy | Diabetic Nephropathy Type 2 | Alport Syndrome

United States, Spain, Korea, Republic of, Australia, Italy, United Kingdom
Universita degli Studi di Genova
Università degli Studi della Campania Luigi Vanvitelli

Recruiting

Intravenous CAngrelor in High-bleeding Risk Patients Undergoing percutaneouS Coronary Intervention (ICARUS) Registry (ICARUS)

Myocardial Infarction | Coronary Artery Disease | Bleeding

Italy
Federico II University

Recruiting

Pharmacodynamic Effects of Cangrelor in ACS or CCS Patients Undergoing PCI (POMPEII Registry) (POMPEII)

Percutaneous Coronary Intervention

Italy
The University of The West Indies

Completed

clOpidogrel "resIstaNce" in a Selected Population of Patients at a Tertiary Cardiovascular Center in Trinidad (POINT)

Platelet Dysfunction

Trinidad and Tobago
Fundacion para la Formacion e Investigacion Sanitarias...

Unknown

Impact of Renal Function on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients (Ticagrelor)

Coronary Artery Disease

Spain
Fondazione Evidence per Attività e Ricerche Cardiovascolari...

Terminated

Second Generation" Drug-Eluting Stents Implantation Followed by Six Versus Twelve-Month - Dual Antiplatelet Therapy

Angina Pectoris | Silent Ischemia

Italy
Hopital du Sacre-Coeur de Montreal

Completed

Effect of Different Dosing Regimens of Clopidogrel Before Elective Percutaneous Coronary Intervention (PCI) on Platelet Function

Coronary Artery Disease

Canada
Sanofi
Bristol-Myers Squibb

Completed

ALBION "Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis"

Ischemia
R&D Cardiologie

Completed

Platelet Inhibition and Transcranial Doppler (TCD)-Detected Microemboli During and After Carotid Artery Stenting (CAS) in Asymptomatic Patients Prior to Cardiac Surgery (IMPACT)

Carotid Stenosis

Netherlands
University of Cologne

Completed

Effects of Clopidogrel on Blood Pressure

Blood Pressure | Endothelial Function | Platelet Function

Germany, Netherlands
Shenyang Northern Hospital

Completed

Clopidogrel Maintaining Dosage in Acute Coronary Syndrome After Drug Eluting Stent Implantation

Acute Coronary Syndrome
Sumitomo Pharma Co., Ltd.

Completed

A Phase III Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia

Schizophrenia

Japan, Korea, Republic of, Malaysia, Taiwan
University of North Carolina, Chapel Hill
Foundation of Hope, North Carolina

Completed

Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Autistic Disorder | Child Development Disorders, Pervasive | Psychosis NOS | Bipolar I Disorder | Asperger Syndrome | Bipolar II Disorder | Severe Major Depression With Psychotic Features | Mood Disorder NOS | Single Episode Major Depression... and other conditions

United States
Sunovion

Completed

PEARL Schizophrenia Maintenance

Schizophrenia

United States, Serbia, South Africa, France, Italy, Russian Federation, Slovakia
Sunovion

Withdrawn

Major Depressive Disorder With Mixed Features (RESOLVE2)

Major Depressive Disorder

United States
Sunovion

Completed

Midazolam Drug-Drug Interaction Study With Lurasidone HCl

Schizophrenia Patients

United States
Fondazione per la Ricerca Ospedale Maggiore

Completed

ADHerence of ticagrelOr in Real World Patients With aCute Coronary Syndrome (AD-HOC)

Acute Coronary Syndrome
Medstar Health Research Institute
AstraZeneca

Completed

NIRS Ticagrelor Evaluation

Coronary Artery Disease
Shiraz University of Medical Sciences
Baqiyatallah university of medical sciences

Completed

Efficacy of Long Term Plavix Therapy Post Angioplasty

Percutaneous Coronary Intervention
Hellenic Cardiovascular Research Society
AstraZeneca

Completed

Compare Ticagrelor vs Clopidogrel on the Reduction of Arterial Stiffness and Wave Reflectionsin Patients With CAD. (NOVELTY)

Coronary Artery Disease

Greece
LifeBridge Health

Unknown

Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Angina, NSTEMI and STEMI Undergoing PCI

Myocardial Infarction | Coronary Artery Disease | Cardiovascular Disease | Stable Angina

United States
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fed Conditions

Healthy

India
St. Antonius Hospital
University of Cologne

Completed

Platelet Reactivity in Stent Thrombosis Patients (MAPCAT)

Coronary Artery Stent Thrombosis

Netherlands
Sanofi
Bristol-Myers Squibb

Completed

Pharmacokinetic Study of Single Doses of Clopidogrel, 75 mg and 300 mg, in Healthy Subjects

Healthy

France
Sheba Medical Center

Completed

Clopidogrel Reloading in Clopidogrel Resistant Patients With ACS

Clopidogrel Non-Responsiveness

Israel
Sumitomo Pharma Co., Ltd.

Completed

Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia

Schizophrenia

Japan, Korea, Republic of, Taiwan
Sumitomo Pharma (Suzhou) Co., Ltd.

Completed

A Clinical Trial of Lurasidone in Treatment of Schizophrenia

Schizophrenia

China

Search clinical trials for: Vasopressin V2 Receptor Antagonist

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations